Evaluating the Optimal Duration of Immunotherapy in Kidney Cancer

por Parikh, Mamta, Lara, Primo N.
Publicado 2022

Immune Checkpoint Inhibitors in the Pre-operative Setting and Impact on the Primary Renal Tumor

por Gulati, Shuchi, Lara, Primo Nery
Publicado 2022

Defining the Optimal Management Strategy for Small Renal Masses

por Dall’Era, Marc, Lara, Primo N.
Publicado 2021

Kidney Cancer: A New Forum for Impactful Scientific Interactions

por Lara, Primo N., Mulders, Peter F.A.
Publicado 2017

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients

por Levandovsky, Mark, Harvey, Danielle, Lara, Primo, Wun, Ted
Publicado 2008

Progress in Personalizing Chemotherapy for Bladder Cancer

por Chang, James S., Lara, Primo N., Pan, Chong-Xian
Publicado 2012

Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer

por Riess, Jonathan W., Lara, Primo N., Gandara, David R.
Publicado 2016

Kidney Cancer Incidence in California: End of the Trend?

por Morris, Cyllene R., Lara, Primo N., Parikh-Patel, Arti, Kizer, Kenneth W.
Publicado 2017

Prospective Evaluation of Low-Dose Ketoconazole Plus Hydrocortisone (HC) in Docetaxel Pre-treated Castration-Resistant Prostate Cancer (CRPC) Patients

por Lo, Ernest N., Beckett, Laurel A., Pan, Chong-Xian, Robles, Daniel, Suga, Jennifer M., Sands, Jacob M., Lara, Primo N.
Publicado 2015

Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer

por Chen, Yixin, Tu, Mei-Juan, Han, Fangwei, Liu, Zhenzhen, Batra, Neelu, Lara, Primo N., Chen, Hong-Wu, Bi, Huichang, Yu, Ai-Ming
Publicado 2023

Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer

por Lin, Tzu-yin, Zhang, Hongyong, Luo, Juntao, Li, Yuanpei, Gao, Tingjuan, Lara, Primo N, de Vere White, Ralph, Lam, Kit S, Pan, Chong-Xian
Publicado 2012

A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial

por Li, Tianhong, Christensen, Scott D., Frankel, Paul H., Margolin, Kim A., Agarwala, Sanjiv S., Luu, Thehang, Mack, Philip C., Lara, Primo N., Gandara, David R.
Publicado 2010

Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed...

por Semrad, Thomas J, Groshen, Susan, Luo, Chunqiao, Pal, Sumanta, Vaishampayan, Ulka, Joshi, Monika, Quinn, David I., Mack, Philip C., Gandara, David R., Lara, Primo N.
Publicado 2019

The Impact of Facility Surgical Caseload Volumes on Survival Outcomes in Patients Undergoing Radical Cystectomy

por Cacciamani, Giovanni E., Barzi, Afsaneh, Eppler, Michael B., Lara, Primo N., Pan, Chong-Xian, Bhanvadia, Sumeet K., Gill, Parkash, Aron, Monish, Gill, Inderbir, Sadeghi, Sarmad
Publicado 2022

A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer

por Wakelee, Heather A., Gettinger, Scott, Engelman, Jeffrey, Jänne, Pasi A., West, Howard, Subramaniam, Deepa S., Leach, Joseph, Wax, Michael, Yaron, Yifah, Miles, Dale R., Lara, Primo N.
Publicado 2017

Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer

por Parikh, Mamta, Liu, Chengfei, Wu, Chun-Yi, Evans, Christopher P., Dall’Era, Marc, Robles, Daniel, Lara, Primo N., Agarwal, Neeraj, Gao, Allen C., Pan, Chong-Xian
Publicado 2021

Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107

por Twardowski, Przemyslaw W., Tangen, Catherine M., Wu, Xiwei, Plets, Melissa R., Plimack, Elizabeth R., Agarwal, Neeraj, Vogelzang, Nicholas J., Wang, Jinhui, Tao, Shu, Thompson, Ian M., Lara, Primo
Publicado 2017

Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG 1216 Phase 3 Trial

por Sayegh, Nicolas, Swami, Umang, Jo, Yeonjung, Gebrael, Georges, Haaland, Benjamin, Gupta, Shilpa, Plets, Melissa, Hussain, Maha H. A., Quinn, David I., Lara, Primo N., Thompson, Ian M., Agarwal, Neeraj
Publicado 2023

In vivo fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapy

por Li, Peng-Cheng, Tu, Mei-Juan, Ho, Pui Yan, Batra, Neelu, Tran, Michelle M.L., Qiu, Jing-Xin, Wun, Theodore, Lara, Primo N., Hu, Xiang, Yu, Ai-Xi, Yu, Ai-Ming
Publicado 2021

Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non–Small-Cell Lung Cancer

por McCoach, Caroline E., Yu, Aiming, Gandara, David R., Riess, Jonathan W., Vang, Daniel P., Li, Tiahong, Lara, Primo N., Gubens, Matthew, Lara, Frances, Mack, Philip C., Beckett, Laurel A., Kelly, Karen
Publicado 2021